US 11618888
Tumor-selective E1A and E1B mutants
granted A61KA61K35/761A61K48/00
Quick answer
US patent 11618888 (Tumor-selective E1A and E1B mutants) held by The Regents of the University of California expires Mon Mar 30 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Apr 04 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 30 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 23
- CPC classes
- A61K, A61K35/761, A61K48/00, A61P, A61P35/00